Plasma concentrations, analgesic and physiological assessments in horses with chronic laminitis treated with two doses of oral tramadol.
Authors: Guedes A, Knych H, Hood D
Journal: Equine veterinary journal
Summary
# Oral Tramadol for Chronic Equine Laminitis: Dose Optimisation and Plasma Kinetics Chronic laminitis remains one of equine medicine's most difficult pain management challenges, and this small study provides useful pharmacokinetic and clinical data on oral tramadol dosing in naturally laminitic horses. Four chronically laminitic horses received either 5 mg/kg or 10 mg/kg tramadol orally every 12 hours for one week (with a washout period between), with researchers measuring plasma drug concentrations, pain-related behaviour (forelimb off-loading frequency), and physiological parameters including heart rate, blood pressure and respiratory function. The higher 10 mg/kg dose produced a clinically meaningful 40% reduction in forelimb off-loading behaviour (P = 0.02), whereas the lower dose showed only a non-significant 9% improvement; notably, neither dose caused adverse physiological changes, suggesting good safety margins for both. Plasma concentrations at 10 mg/kg (peak tramadol concentrations of 628–1330 μg/L and metabolite M2 of 239–362 μg/L) fell within ranges considered analgesic in other species, while the 5 mg/kg dose appeared subtherapeutic. For practitioners managing chronic laminitis cases, these findings suggest that 10 mg/kg tramadol administered twice daily may offer a safer oral analgesic option than some alternatives, though the small sample size warrants cautious interpretation and further investigation in larger populations.
Read the full abstract on PubMed
Practical Takeaways
- •10 mg/kg oral tramadol twice daily appears more effective for chronic laminitis pain than 5 mg/kg, producing meaningful reduction in weight-shifting behavior without apparent adverse physiological effects
- •This dosage regimen may be considered as part of a multimodal pain management strategy for chronic laminitis cases where traditional options are inadequate
- •Oral tramadol at therapeutic doses does not appear to compromise cardiovascular or gastrointestinal function in laminitic horses, supporting safety for longer-term use
Key Findings
- •10 mg/kg tramadol twice daily decreased forelimb off-loading frequency by 40% (P=0.02), whereas 5 mg/kg produced only 9% decrease (P=0.4)
- •Maximum plasma tramadol concentrations ranged from 329-728 μg/l at 5 mg/kg and 628-1330 μg/l at 10 mg/kg
- •Physiological variables including heart rate, respiratory rate, blood pressure and intestinal sounds showed no significant changes with either treatment
- •Area under the concentration-time curve doubled from 727 to 1426 h·μg/l when dose increased from 5 to 10 mg/kg